Abiopharma

🔍 Papadopoulos Didier (Executive)

Company: Joby Aviation, Inc. (JOBY)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 7,599 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 143,140.00 | transaction_form_type: 4
• Acquired 12,458 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 155,598.00 | transaction_form_type: 4
• Acquired 5,045 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 160,643.00 | transaction_form_type: 4
• Sold 12,965 shares of Common Stock at $8.15 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 147,678.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 7,599 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 37,994.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Sold 12,458 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 87,210.00 | transaction_form_type: 4 | Footnotes: F4, F4
• Sold 5,045 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 95,863.00 | transaction_form_type: 4 | Footnotes: F5, F5

Footnotes:

• F1: Represents the aggregate number of shares sold by the Reporting Person to cover taxes due upon the release and settlement of the RSUs, as required by the terms of the RSU award.
• F2: This transaction was executed in multiple trades at prices ranging from $8.15 to $8.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: Represents an award of restricted stock units ("RSUs") that vests in equal installments over four years, on the quarterly anniversary of July 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
• F4: Represents an award of restricted stock units ("RSUs") that vest in 16 equal installments on the quarterly anniversary of January 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.
• F5: Represents an award of restricted stock units ("RSUs") that vests with respect to 5% of the total number of RSUs on each of the first four quarterly anniversaries of January 1, 2026 and as to 10% of the total number of RSUs on each quarterly anniversary thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the contingent right to receive one share of Common Stock upon vesting.